Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 10
1966 32
1967 44
1968 53
1969 33
1970 32
1971 43
1972 38
1973 47
1974 38
1975 47
1976 29
1977 24
1978 27
1979 25
1980 11
1981 17
1982 14
1983 15
1984 13
1985 8
1986 13
1987 13
1988 14
1989 11
1990 11
1991 10
1992 8
1993 17
1994 12
1995 8
1996 19
1997 18
1998 18
1999 8
2000 10
2001 3
2002 8
2003 10
2004 12
2005 8
2006 5
2007 11
2008 4
2009 7
2010 4
2011 7
2012 1
2013 4
2014 5
2015 1
2016 4
2017 2
2018 5
2019 4
2020 3
2021 4
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

901 results

Results by year

Filters applied: . Clear all
Page 1
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
Kane J, Honigfeld G, Singer J, Meltzer H. Kane J, et al. Arch Gen Psychiatry. 1988 Sep;45(9):789-96. doi: 10.1001/archpsyc.1988.01800330013001. Arch Gen Psychiatry. 1988. PMID: 3046553 Clinical Trial.
Patients whose condition remained unimproved were then randomly assigned, in a double-blind manner, to clozapine (up to 900 mg/d) or chlorpromazine (up to 1800 mg/d) for six weeks. Two hundred sixty-eight patients were entered in the double-blind comparison. When a priori …
Patients whose condition remained unimproved were then randomly assigned, in a double-blind manner, to clozapine (up to 900 mg/d) or chlo …
Placebo revisited.
Lavori PW, Sugarman J. Lavori PW, et al. Acta Psychiatr Scand. 2000 Mar;101(3):173-5. doi: 10.1034/j.1600-0447.2000.101003173.x. Acta Psychiatr Scand. 2000. PMID: 10721865 Clinical Trial. No abstract available.
A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
Chouinard G. Chouinard G. Acta Psychiatr Scand Suppl. 1990;358:111-9. doi: 10.1111/j.1600-0447.1990.tb05301.x. Acta Psychiatr Scand Suppl. 1990. PMID: 1978469 Clinical Trial.
We carried out a four-week double-blind placebo-controlled study comparing remoxipride (n = 20) to chlorpromazine (n = 21) and placebo (n = 21) in the treatment of newly admitted schizophrenic patients with acute exacerbation. Chlorpromazine was found to be signific …
We carried out a four-week double-blind placebo-controlled study comparing remoxipride (n = 20) to chlorpromazine (n = 21) and placeb …
Rapid tranquillisation in a psychiatric emergency hospital in Lebanon: TREC-Lebanon - a pragmatic randomised controlled trial of intramuscular haloperidol and promethazine v. intramuscular haloperidol, promethazine and chlorpromazine.
Dib JE, Yaacoub HE, Ikdais WH, Atallah E, Merheb TJ, Ajaltouni J, Akkari M, Mourad M, Nasr ME, Hachem D, Kazour F, Tahan F, Haddad G, Azar J, Zoghbi M, Haddad C, Hallit S, Adams CE. Dib JE, et al. Psychol Med. 2022 Oct;52(13):2751-2759. doi: 10.1017/S0033291720004869. Epub 2021 Jan 6. Psychol Med. 2022. PMID: 33402230 Clinical Trial.
In Lebanon, the use of the triple therapy haloperidol plus promethazine plus chlorpromazine (HPC) is frequently used but no studies involving this combination exists. ...If clinicians are faced with uncertainty on which of the two intervention combinations to use, the simp …
In Lebanon, the use of the triple therapy haloperidol plus promethazine plus chlorpromazine (HPC) is frequently used but no studies i …
Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis.
Cookson J, Silverstone T, Wells B. Cookson J, et al. Acta Psychiatr Scand. 1981 Nov;64(5):381-97. doi: 10.1111/j.1600-0447.1981.tb00797.x. Acta Psychiatr Scand. 1981. PMID: 7051755 Clinical Trial.
Pimozide (PMZ), a relatively specific dopamine (DA) receptor blocking drug, was compared to chlorpromazine (CPZ) in a double-blind, between-patient clinical trial in mania. ...According to one of the two rating scales used, initial improvement was greater with chlorprom …
Pimozide (PMZ), a relatively specific dopamine (DA) receptor blocking drug, was compared to chlorpromazine (CPZ) in a double-blind, b …
Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers.
Hughes AM, Lynch P, Rhodes J, Ervine CM, Yates RA. Hughes AM, et al. Br J Clin Pharmacol. 1999 Sep;48(3):323-30. doi: 10.1046/j.1365-2125.1999.00021.x. Br J Clin Pharmacol. 1999. PMID: 10510142 Free PMC article. Clinical Trial.
On each trial day volunteers were dosed twice. Dose 1 consisting of either chlorpromazine 50 mg or placebo to chlorpromazine, and dose 2 either risperidone 2 mg or placebo to risperidone. The volunteers were randomized so that each received either chlorpromazine …
On each trial day volunteers were dosed twice. Dose 1 consisting of either chlorpromazine 50 mg or placebo to chlorpromazine, …
Chlorpromazine, placebo and droperidol in the treatment of nausea and vomiting associated with cisplatin therapy.
Stuart-Harris R, Buckman R, Starke I, Wiltshaw E. Stuart-Harris R, et al. Postgrad Med J. 1983 Aug;59(694):500-3. doi: 10.1136/pgmj.59.694.500. Postgrad Med J. 1983. PMID: 6353396 Free PMC article. Clinical Trial.
Chlorpromazine was statistically superior to placebo in the control of nausea and vomiting in those patients treated with chlorpromazine had significantly less nausea than with droperidol, but there were no other significant differences between chlorpromazine …
Chlorpromazine was statistically superior to placebo in the control of nausea and vomiting in those patients treated with chlorpro …
Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
Wode-Helgodt B, Borg S, Fyrö B, Sedvall G. Wode-Helgodt B, et al. Acta Psychiatr Scand. 1978 Aug;58(2):149-73. doi: 10.1111/j.1600-0447.1978.tb06929.x. Acta Psychiatr Scand. 1978. PMID: 358755 Clinical Trial.
The clinical effects of chlorpromazine (CPZ) administered in accordance with a double-blind design in one of three doses (200, 400 or 600 mg) were examined in 44 psychotic patients. ...
The clinical effects of chlorpromazine (CPZ) administered in accordance with a double-blind design in one of three doses (200, 400 or …
A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes.
Li H, Shen Y, Wang G, Shi J, Ma C, Xie S, Zhang H, Wang X, Li K, Xu X, Gu N. Li H, et al. Psychiatry Res. 2018 Jan;259:117-124. doi: 10.1016/j.psychres.2017.07.006. Epub 2017 Jul 22. Psychiatry Res. 2018. PMID: 29040947 Clinical Trial.
Changes in PANSS total score were -33.4 for quetiapine XR and -35.9 for chlorpromazine (P > 0.05). Least squares mean changes were: positive subscale, -9.9 0.53 and -11.1 0.51; negative subscale, -5.9 0.50 and -6.7 0.48; general psychopathology subscale, -12.9 0.74 and …
Changes in PANSS total score were -33.4 for quetiapine XR and -35.9 for chlorpromazine (P > 0.05). Least squares mean changes were …
901 results